Pediatric Lung Disease: Pathogenesis and Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 132
Special Issue Editors
Interests: clinical investigation; translational research; pulmonology; allergology; cystic fibrosis
Interests: clinical investigation; translational research; pulmonology; allergology; cystic fibrosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lung diseases are amongst the leading causes of morbidity and mortality worldwide, with lung infections and chronic lung diseases being the top 10 causes of death in 2008. The burden of lung disease is also evident in the pediatric population, and this pushes physicians as well as researchers to improve patient outcomes by developing novel therapies and devices that can influence disease pathogenesis, course, and prognosis. This Special Issue aims to inform the reader of the clinical and research advances in lung diseases. In this regard, precision medicine, and specifically artificial intelligence, have evolved significantly. The developments in thoracic pathology, imaging, and treatment are meaningful components that play a role in bringing research findings to the bedside. Accordingly, thanks to algorithms, all of these findings can be analyzed and used for the betterment of patients afflicted by different thoracic diseases.
Globally, this Special Issue will accept high-quality research papers and original articles that have immediate relevance to clinical practice as well as multidisciplinary perspectives, reflecting the nature of modern treatment. This Special Issue will provide a multidisciplinary focus, publishing original papers, reviews, and commentaries on acute and chronic respiratory disease in addition to clinically focused treatment and management.
Dr. Sara Manti
Dr. Salvatore Leonardi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatrics
- congenital lung diseases
- acquired lung diseases
- allergology
- pulmonology
- infections
- cystic fibrosis
